23 maj: Dom Pérignon 2003 frigivet
26 maj: Skattereform 2012
24-05-2012 17:05:00

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associate

Relateret indhold
18 okt - 
Lundbeck: Rygter om Schultz-stop ved udgangen af oktobe..
16 okt - 
Mandagens aktier: Tunge Novo tvang pilen i positiv retn..
16 okt - 
Aktier/middag: Retræte fra rekord fortsætter med Vestas..
Relateret debat
16 okt - 
Saxo Trader 2.
16 okt - 
Hvilken platform bruger I til at shorte?
16 okt - 
Rebound fra Vestas slået fejl - indtil videre. Re..

H. Lundbeck A/S hereby reports transactions made by executives and persons and

legal entities closely associated to them with shares in H. Lundbeck A/S and

linked securities, cf. section 28a of the Danish Securities Trading Act.

The list is based on reports received by H. Lundbeck A/S from the company's

executives today or yesterday.

Name: Anders Gersel Pedersen

Job position of the Executive Vice President &

executive: Head of Research & Development

ID code (ISIN code): DK 0010287234

Description of the Share

security:

Nature of the transaction: Transferred as part of Lundbeck’s Long Term

Incentive Program for Executive Management

Date of trading: 23 May 2012

Market on which the Nasdaq OMX Copenhagen

trading was effected:

Number of traded 33,583 shares

securities:

Persons or entities under an obligation to report are defined as members of the

Executive Management and the Supervisory Board of H. Lundbeck A/S and

persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

-- spouse or cohabitant

-- children below the age of 18

-- legal entities in which the insider has a controlling influence

The content of this release will have no influence on the Lundbeck Group’s

financial expectations for 2012.

Lundbeck contacts

Investors: Media:

Palle Holm Olesen Mads Kronborg

Chief Specialist, Head of Investor Relations Media Relations Manager

palo@lundbeck.com mavk@lundbeck.com

+45 36 43 24 26 +45 36 43 28 51

Magnus Thorstholm Jensen Simon Mehl Augustesen

Investor Relations Officer International Media Specialist

matj@lundbeck.com smeh@lundbeck.com

+45 36 43 38 16 +45 36 43 49 80

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is an international pharmaceutical

company highly committed to improving the quality of life for people suffering

from brain disorders. For this purpose, Lundbeck is engaged in the research,

development, production, marketing and sale of pharmaceuticals across the

world. The company’s products are targeted at disorders such as depression and

anxiety, psychotic disorders, epilepsy and Huntington’s, Alzheimer’s and

Parkinson’s diseases.

Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today

Lundbeck employs approximately 6,000 people worldwide. Lundbeck is one of the

world’s leading pharmaceutical companies working with brain disorders. In 2011,

the company's revenue was DKK 16.0 billion (approximately EUR 2.1 billion or

USD 3.0 billion). For more information, please visit www.lundbeck.com.

Vedhæftet fil: Release no 471_1.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Mærsk: Spotrater på Asien-Europa fortsætter faldet

20-10-2017 16:04:59
Spotpriserne for containerfragt på de vigtige ruter mellem Asien og Europa faldt i denne uge med 0,7 pct. til 681 dollar per tyvefodscontainer (teu).Det skriver branchemediet Journal of Commerce, der henviser til data fra Shanghai Shipping Exchange.Spotprisen på verdens travleste handelsrute fortsætter derfor de negative tendenser, der også gjorde sig gældende i sidste uge, hvor spotpriserne faldt..

Novo: Fiasp godkendt i USA

29-09-2017 16:20:48
De amerikanske sundhedsmyndigheder, FDA, har godkendt Fiasp (hurtigtvirkende insulin aspart), en ny hurtigtvirkende måltidsinsulin, til behandling af voksne med diabetes.Det oplyser Novo Nordisk.FDA's beslutning kommer, efter at kliniske studier har dokumenteret, at Fiasp giver fordele for mennesker, der har behov for en forbedret generel blodsukkerregulering.- Vi er meget glade for, at Fiasp nu o..

Atlantic Petroleum: Direktør fratræder 1. december

29-09-2017 14:02:37
Topchefen for Atlantic Petroleum, der er noteret i Norge og København, direktør Ben Arabo, har opsagt sit job for at tiltræde et andet job på Færøerne.Det oplyser selskabet.Han vil dog blive hos Atlantic Petroleum til 1. december./ritzau/FINANSClaus Mikkelsen +45 33 30 03 35 Ritzau Finans, E-mail: finans@ritzau.dk , www.ritzaufinans.dk

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo/SHB: Kursmål sættes op til 403 kr. fra 357 kr. - NY
2
Storbanks mistænkte valutasvindel fanget på bånd
3
Asien: Abe-sejr løfter Nikkei til rekordstime
4
Spanien/Catalansk leder: Værste angreb siden Franco
5
Japan: Shinzo Abes førsteprioritet efter valgsejr er Nordkorea

Relaterede aktiekurser

Lundbeck A/S 381,00 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. oktober 2017 08:21:31
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171020.1 - EUROWEB7 - 2017-10-23 08:21:31 - 2017-10-23 08:21:31 - 1 - Website: OKAY